Tag Archives: cancer

FDA Approves Merck’s Keytruda (pembrolizumab) Plus Chemotherapy, With or Without Bevacizumab, as Treatment for Patients With Persistent, Recurrent or Metastatic Cervical Cancer Whose Tumors Express PD-L1 (CPS ≥1)

[unable to retrieve full-text content]KENILWORTH, N.J.–(BUSINESS WIRE) October 13, 2021 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in… Drugs.com – New Drug Approvals

“Blood test finds 50 types of cancer” – we’ve been down this path before

Shoddy, incomplete, fawning news coverage of screening tests is one of the most clearly established problems in health news coverage – something HealthNewsReview.org has revealed countless times over the past 15 years. A public relations news release 22 days ago – from “a healthcare company whose mission is to detect cancer early” – touted study… Read More »

U.S. FDA Grants Regular Approval and Expands Indication for Padcev (enfortumab vedotin-ejfv) for Patients with Locally Advanced or Metastatic Urothelial Cancer

Regular Approval Based on Overall Survival Results from Confirmatory EV-301 Trial First and Only FDA-Approved Therapy for Urothelial Cancer Patients Who Are Cisplatin-Ineligible and Have Previously Received One or More Prior Therapies, Based on Cohort 2 of Pivotal EV-201 Trial TOKYO and BOTHELL, Wash., July 9, 2021 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President… Read More »